Time for a Change? Looking Ahead at New Treatment Strategies for the Management of Dyslipidemia

Publication
Article
Pharmacy TimesJuly 2015 Digestive Health
Volume 81
Issue 7

This Continuing Education activity is supported by an educational grant from Merck Sharp & Dohme Corp.

This activity is supported by an educational grant from Merck Sharp & Dohme Corp.

Time for a Change? Looking Ahead at New Treatment Strategies for the Management of Dyslipidemia

Faculty

Patrick Curtin PharmD, BCPS

Clinical Coordinator

Overlook Medical Center

Summit, New Jersey

Educational Objectives

After completing this continuing education program, the participant will be able to:

  • Examine the changes to previous guidelines as presented in the 2013 American Heart Association/ American College of Cardiology lipid guidelines.
  • Determine the use of the pooled cohort equations for the assessment of patients’ 10-year atherosclerotic cardiovascular risk.
  • Identify available and investigational medications and treatment strategies to develop patient-specific management of dyslipidemia.

Target audience:

Pharmacists

Type of activity:

Application

Release date:

July 6, 2015

Expiration date:

July 6, 2017

Estimated time to complete activity

: 2.0 hours

Fee:

Free

Pharmacy Times Office of Continuing Professional Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.

This activity is approved for 2.0 contact hours (0.2 CEUs) under the ACPE universal activity number 0290-0000-15-068-H01-P. The activity is available for CE credit through July 6, 2017.

Related Videos
Practice Pearl #1 Active Surveillance vs Treatment in Patients with NETs
© 2024 MJH Life Sciences

All rights reserved.